- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This comprehensive second edition reflects the remarkable evolution in adaptive clinical trial methodology over the past two decades. Since publication of the first edition, these approaches have transformed from theoretical concepts to widely accepted practices, now endorsed by regulatory authorities, including formal FDA guidance.
Andere Kunden interessierten sich auch für
- Gernot WassmerGroup Sequential and Confirmatory Adaptive Designs in Clinical Trials106,99 €
- Shein-Chung ChowAdaptive Design Methods in Clinical Trials59,99 €
- John WhiteheadThe Design and Analysis of Sequential Clinical Trials161,99 €
- Lawrence M FriedmanFundamentals of Clinical Trials85,59 €
- Lawrence M FriedmanFundamentals of Clinical Trials54,99 €
- Geraldine RauchPlanning and Analyzing Clinical Trials with Composite Endpoints106,99 €
- Michael A. ProschanStatistical Monitoring of Clinical Trials106,99 €
-
-
-
This comprehensive second edition reflects the remarkable evolution in adaptive clinical trial methodology over the past two decades. Since publication of the first edition, these approaches have transformed from theoretical concepts to widely accepted practices, now endorsed by regulatory authorities, including formal FDA guidance.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis Inc
- 2. Auflage
- Seitenzahl: 632
- Erscheinungstermin: 8. Dezember 2025
- Englisch
- Abmessung: 254mm x 178mm
- Gewicht: 453g
- ISBN-13: 9781584888475
- ISBN-10: 1584888474
- Artikelnr.: 22727944
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Taylor & Francis Inc
- 2. Auflage
- Seitenzahl: 632
- Erscheinungstermin: 8. Dezember 2025
- Englisch
- Abmessung: 254mm x 178mm
- Gewicht: 453g
- ISBN-13: 9781584888475
- ISBN-10: 1584888474
- Artikelnr.: 22727944
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Christopher Jennison is Professor of Statistics in the Department of Mathematical Sciences, University of Bath, UK. He has worked on the analysis of clinical trials at the Dana-Farber Cancer Institute, Boston and collaborated with medical researchers in areas such as cancer research, cardiology, gynaecology, and complementary medicine. Bruce Turnbull is Emeritus Professor of Statistics in the School of Operations Research & Industrial Engineering and in the Department of Statistical Science, Cornell University, USA. He has a long experience of designing, monitoring, and analyzing clinical trials and has served on the Data Safety Monitoring Boards for international, multi-center trials for the treatment or prevention of cancer, heart disease and AIDS. He has also served as a consultant to pharmaceutical companies and health-related government review panels.
1. Introduction. 2. Two-sided Tests: Introduction. 3. A Unified Formulation
and the General Calculation. 4. Two-sided Tests: General Applications. 5.
One-Sided Tests. 6. Two-Sided Tests with Early Stopping Under the Null
Hypothesis. 7. Tests for Equivalence and Non-inferiority. 8. Information
Monitoring: The Error Spending Approach. 9. Analysis Following a Sequential
Test. 10. Repeated Coincidence Intervals. 11. Stochastic Curtailment. 12.
Optimal Group Sequential Tests. 13. Bayesian Approaches. 14. Group
Sequential Tests for Delayed Observations. 15. General Group Sequential
Distribution Theory. 16. Binary Data. 17. Survival Data. 18. Nuisance
Parameters: Internal Pilot Studies, Sample Size Re-estimation and
Information Monitoring. 19. Multivariate Endpoints. 20. Multiple
Hypotheses: Primary and Secondary Endpoints. 21. Multi-arm Multi-stage
Trials. 22. From Group Sequential to Adaptive Designs: Flexible Sample Size
Re-assessment. 23. Adaptive Combination Tests. 24. Sample Size
Re-assessment given an Interim Estimate of Treatment Effect . 25. Adaptive
Trials Testing Multiple Hypotheses: Closed Testing Procedures with
Combination Tests. 26. Treatment Selection and Testing: Seamless Phase
II/III Trials. 27. Adaptive Multi-arm Multi-stage Phase III Trials. 28.
Enrichment Designs: Targeting Therapies to Selected Sub-populations. 29.
Adaptive Seamless Design: A Case Study with Intermediate and Long- Term
Survival Endpoints. 30. Response Adaptive Treatment Assignment. 31.
Numerical Computations for Group Sequential and Adaptive Tests.
and the General Calculation. 4. Two-sided Tests: General Applications. 5.
One-Sided Tests. 6. Two-Sided Tests with Early Stopping Under the Null
Hypothesis. 7. Tests for Equivalence and Non-inferiority. 8. Information
Monitoring: The Error Spending Approach. 9. Analysis Following a Sequential
Test. 10. Repeated Coincidence Intervals. 11. Stochastic Curtailment. 12.
Optimal Group Sequential Tests. 13. Bayesian Approaches. 14. Group
Sequential Tests for Delayed Observations. 15. General Group Sequential
Distribution Theory. 16. Binary Data. 17. Survival Data. 18. Nuisance
Parameters: Internal Pilot Studies, Sample Size Re-estimation and
Information Monitoring. 19. Multivariate Endpoints. 20. Multiple
Hypotheses: Primary and Secondary Endpoints. 21. Multi-arm Multi-stage
Trials. 22. From Group Sequential to Adaptive Designs: Flexible Sample Size
Re-assessment. 23. Adaptive Combination Tests. 24. Sample Size
Re-assessment given an Interim Estimate of Treatment Effect . 25. Adaptive
Trials Testing Multiple Hypotheses: Closed Testing Procedures with
Combination Tests. 26. Treatment Selection and Testing: Seamless Phase
II/III Trials. 27. Adaptive Multi-arm Multi-stage Phase III Trials. 28.
Enrichment Designs: Targeting Therapies to Selected Sub-populations. 29.
Adaptive Seamless Design: A Case Study with Intermediate and Long- Term
Survival Endpoints. 30. Response Adaptive Treatment Assignment. 31.
Numerical Computations for Group Sequential and Adaptive Tests.
1. Introduction. 2. Two-sided Tests: Introduction. 3. A Unified Formulation
and the General Calculation. 4. Two-sided Tests: General Applications. 5.
One-Sided Tests. 6. Two-Sided Tests with Early Stopping Under the Null
Hypothesis. 7. Tests for Equivalence and Non-inferiority. 8. Information
Monitoring: The Error Spending Approach. 9. Analysis Following a Sequential
Test. 10. Repeated Coincidence Intervals. 11. Stochastic Curtailment. 12.
Optimal Group Sequential Tests. 13. Bayesian Approaches. 14. Group
Sequential Tests for Delayed Observations. 15. General Group Sequential
Distribution Theory. 16. Binary Data. 17. Survival Data. 18. Nuisance
Parameters: Internal Pilot Studies, Sample Size Re-estimation and
Information Monitoring. 19. Multivariate Endpoints. 20. Multiple
Hypotheses: Primary and Secondary Endpoints. 21. Multi-arm Multi-stage
Trials. 22. From Group Sequential to Adaptive Designs: Flexible Sample Size
Re-assessment. 23. Adaptive Combination Tests. 24. Sample Size
Re-assessment given an Interim Estimate of Treatment Effect . 25. Adaptive
Trials Testing Multiple Hypotheses: Closed Testing Procedures with
Combination Tests. 26. Treatment Selection and Testing: Seamless Phase
II/III Trials. 27. Adaptive Multi-arm Multi-stage Phase III Trials. 28.
Enrichment Designs: Targeting Therapies to Selected Sub-populations. 29.
Adaptive Seamless Design: A Case Study with Intermediate and Long- Term
Survival Endpoints. 30. Response Adaptive Treatment Assignment. 31.
Numerical Computations for Group Sequential and Adaptive Tests.
and the General Calculation. 4. Two-sided Tests: General Applications. 5.
One-Sided Tests. 6. Two-Sided Tests with Early Stopping Under the Null
Hypothesis. 7. Tests for Equivalence and Non-inferiority. 8. Information
Monitoring: The Error Spending Approach. 9. Analysis Following a Sequential
Test. 10. Repeated Coincidence Intervals. 11. Stochastic Curtailment. 12.
Optimal Group Sequential Tests. 13. Bayesian Approaches. 14. Group
Sequential Tests for Delayed Observations. 15. General Group Sequential
Distribution Theory. 16. Binary Data. 17. Survival Data. 18. Nuisance
Parameters: Internal Pilot Studies, Sample Size Re-estimation and
Information Monitoring. 19. Multivariate Endpoints. 20. Multiple
Hypotheses: Primary and Secondary Endpoints. 21. Multi-arm Multi-stage
Trials. 22. From Group Sequential to Adaptive Designs: Flexible Sample Size
Re-assessment. 23. Adaptive Combination Tests. 24. Sample Size
Re-assessment given an Interim Estimate of Treatment Effect . 25. Adaptive
Trials Testing Multiple Hypotheses: Closed Testing Procedures with
Combination Tests. 26. Treatment Selection and Testing: Seamless Phase
II/III Trials. 27. Adaptive Multi-arm Multi-stage Phase III Trials. 28.
Enrichment Designs: Targeting Therapies to Selected Sub-populations. 29.
Adaptive Seamless Design: A Case Study with Intermediate and Long- Term
Survival Endpoints. 30. Response Adaptive Treatment Assignment. 31.
Numerical Computations for Group Sequential and Adaptive Tests.